These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11169777)

  • 1. Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.
    Zubieta JK; Koeppe RA; Frey KA; Kilbourn MR; Mangner TJ; Foster NL; Kuhl DE
    Synapse; 2001 Mar; 39(4):275-87. PubMed ID: 11169777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding.
    Zubieta JK; Koeppe RA; Mulholland GK; Kuhl DE; Frey KA
    J Cereb Blood Flow Metab; 1998 Jun; 18(6):619-31. PubMed ID: 9626186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer's disease patients on 11C-N-methyl-4-piperidyl benzilate--comparison with cerebral blood flow and cerebral glucose metabolism.
    Yoshida T; Kuwabara Y; Ichiya Y; Sasaki M; Fukumura T; Ichimiya A; Takita M; Ogomori K; Masuda K
    Ann Nucl Med; 1998 Feb; 12(1):35-42. PubMed ID: 9559960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muscarinic cholinergic receptor imaging of parkinsonian brain using 11C-NMPB and PET].
    Asahina M; Shinotoh H
    Nihon Rinsho; 1997 Jan; 55(1):233-7. PubMed ID: 9014456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-related differences in the muscarinic acetylcholinergic receptor in the healthy human brain--a positron emission tomography study.
    Yoshida T; Kuwabara Y; Sasaki M; Fukumura T; Ichimiya A; Takita M; Ogomori K; Ichiya Y; Masuda K
    Ann Nucl Med; 2000 Apr; 14(2):97-101. PubMed ID: 10830526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
    Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
    Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection.
    Buck A; Mulholland GK; Papadopoulos SM; Koeppe RA; Frey KA
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1280-7. PubMed ID: 8898702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of muscarinic cholinergic receptor ligands N-[11C]ethyl-4-piperidyl benzilate and N-[11C]propyl-4-piperidyl benzilate: a PET study in comparison with N-[11C]methyl-4-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Sato K; Harada N; Kakiuchi T; Tsukada H
    Nucl Med Biol; 2000 Nov; 27(8):733-40. PubMed ID: 11150704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
    Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding kinetics of 11C-N-methyl piperidyl benzilate (11C-NMPB) in a rhesus monkey brain using the cerebellum as a reference region.
    Itoh T; Tanaka M; Kobayashi K; Suzuki K; Inoue O
    Ann Nucl Med; 2005 Sep; 19(6):499-505. PubMed ID: 16248387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vivo binding properties of 3H-NMPB and 3H-QNB in mouse brain.
    Hosoi R; Kobayashi K; Watanabe Y; Inoue O
    J Neural Transm (Vienna); 1999; 106(7-8):583-92. PubMed ID: 10907719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography.
    Suhara T; Inoue O; Kobayashi K; Suzuki K; Tateno Y
    Neurosci Lett; 1993 Jan; 149(2):225-8. PubMed ID: 8474698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate.
    Lee KS; Frey KA; Koeppe RA; Buck A; Mulholland GK; Kuhl DE
    J Cereb Blood Flow Metab; 1996 Mar; 16(2):303-10. PubMed ID: 8594063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
    Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
    Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.
    Koeppe RA; Frey KA; Mulholland GK; Kilbourn MR; Buck A; Lee KS; Kuhl DE
    J Cereb Blood Flow Metab; 1994 Jan; 14(1):85-99. PubMed ID: 8263062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptors in human narcolepsy: a PET study.
    Sudo Y; Suhara T; Honda Y; Nakajima T; Okubo Y; Suzuki K; Nakashima Y; Yoshikawa K; Okauchi T; Sasaki Y; Matsushita M
    Neurology; 1998 Nov; 51(5):1297-302. PubMed ID: 9818849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor occupancy by biperiden in living human brain.
    Sudo Y; Suhara T; Suzuki K; Okubo Y; Yoshikawa K; Uchida S; Sassa T; Okauchi T; Sasaki Y; Matsushita M
    Life Sci; 1999; 64(8):PL99-104. PubMed ID: 10069534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
    Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography.
    Frey KA; Koeppe RA; Mulholland GK; Jewett D; Hichwa R; Ehrenkaufer RL; Carey JE; Wieland DM; Kuhl DE; Agranoff BW
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):147-54. PubMed ID: 1727135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.